Home> Products> cilostazol for intermittent claudication

{ "products": [ { "_id": "666975897e4bb91e3091ff69", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CILOSTAZONE 100 ", "description": "CILOSTAZONE 100 \nCilostazol (100mg)\nIntroduction\nCILOSTAZONE 100 contains Cilostazol (100 mg), a potent medication used to treat the symptoms of intermittent claudication in individuals with peripheral artery disease (PAD). By improving blood flow and reducing pain during physical activity, Cilostazol enables patients to walk longer distances and engage more comfortably in daily activities.\n\nKey Ingredient and Its Benefits\nCilostazol (100 mg)\nImproved Blood Flow: Cilostazol works by inhibiting phosphodiesterase III, leading to an increase in cyclic AMP levels, which causes vasodilation and improves blood flow to the limbs.\nReduced Pain: It effectively reduces pain and discomfort in the legs associated with intermittent claudication, allowing patients to walk longer distances without pain.\nPlatelet Aggregation Inhibition: Cilostazol inhibits platelet aggregation, reducing the risk of blood clots and enhancing cardiovascular health.\nEnhanced Physical Activity: By alleviating symptoms of intermittent claudication, Cilostazol helps patients increase their physical activity and improve overall fitness.\nBenefits of CILOSTAZONE 100\nEffective Symptom Relief: CILOSTAZONE 100 provides robust relief from intermittent claudication symptoms, significantly reducing pain and discomfort in the legs.\nImproved Circulation: The medication enhances blood flow to the extremities, improving circulation and overall vascular health.\nIncreased Mobility: By reducing pain during walking, CILOSTAZONE 100 enables patients to increase their mobility and engage more actively in daily activities.\nPrevention of Blood Clots: Cilostazol’s platelet aggregation inhibition properties help prevent blood clot formation, reducing the risk of cardiovascular events.\nDosage and Administration\nDosage\nIntermittent Claudication: The typical dosage for adults is one tablet (100 mg) taken twice daily, 30 minutes before or 2 hours after breakfast and dinner. The dosage may be adjusted by the healthcare provider based on the patient’s response and specific health needs.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. It should be taken on an empty stomach, either 30 minutes before or 2 hours after meals.\nConsistency: For optimal results, take CILOSTAZONE 100 at the same times each day to maintain consistent medication levels in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/cilostazone-100-133550", "price": 191.5, "discountamount": 57.45, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "PAD", "risk", "legs", "Order", "EMAIL", "limbs", "meals", "water", "adults", "dinner", "walking", "patients", "response", "Benefits", "Oral Use", "breakfast", "Prevention", "Cilostazol", "same times", "discomfort", "one tablet", "full glass", "individuals", "CILOSTAZONE", "extremities", "blood clots", "Consistency", "bloodstream", "information", "Introduction", "sterispharma", "vasodilation", "Reduced Pain", "sterisonline", "CALL/WHATSAPP", "robust relief", "empty stomach", "typical dosage", "Key Ingredient", "overall fitness", "optimal results", "daily activities", "longer distances", "potent medication", "cyclic AMP levels", "Increased Mobility", "Improved Blood Flow", "healthcare provider", "blood clot formation", "Improved Circulation", "cardiovascular events", "cardiovascular health", "specific health needs", "Administration Dosage", "phosphodiesterase III", "overall vascular health", "Effective Symptom Relief", "peripheral artery disease", "Enhanced Physical Activity", "consistent medication levels", "intermittent claudication symptoms", "platelet aggregation inhibition properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1815, "imageuri": "https://productimages.withfloats.com/actual/6669758c8c6c791fd3b357ad.png", "tileimageuri": "https://productimages.withfloats.com/tile/6669758c8c6c791fd3b357ad.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T10:16:41.937Z", "updatedon": "2024-06-27T06:01:08.361Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cilostazone-100-/1815", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CILOSTAZONE 100 ", "category": "NEUROLOGY RANGE", "tags": [ "CILOSTAZONE 100", "Cilostazol 100mg price", "Cilostazol 100mg", "Cilostazol (100mg) usess", "", "Cilostazol mechanism of action", "cilostazol side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6669749c70774b1f84f67b0d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CILOSTAZONE 50 ", "description": "CILOSTAZONE 50 \nCilostazol (50mg)\nIntroduction\nCILOSTAZONE 50 contains Cilostazol (50 mg), a medication used primarily to treat the symptoms of intermittent claudication in people with peripheral artery disease (PAD). By improving blood flow and reducing pain while walking, Cilostazol helps patients increase their physical activity and enhance their quality of life.\n\nKey Ingredient and Its Benefits\nCilostazol (50 mg)\nImproved Blood Flow: Cilostazol works by inhibiting phosphodiesterase III, leading to an increase in cyclic AMP levels and vasodilation, which improves blood flow to the limbs.\nReduced Pain: It helps reduce pain and discomfort in the legs caused by poor blood circulation, allowing patients to walk longer distances without pain.\nPlatelet Aggregation Inhibition: Cilostazol inhibits platelet aggregation, reducing the risk of blood clots and improving overall cardiovascular health.\nEnhanced Physical Activity: By alleviating symptoms of intermittent claudication, Cilostazol enables patients to engage in more physical activities and improve their overall fitness.\nBenefits of CILOSTAZONE 50\nEffective Symptom Relief: CILOSTAZONE 50 provides effective relief from the symptoms of intermittent claudication, reducing pain and discomfort in the legs.\nImproved Circulation: The medication enhances blood flow to the limbs, improving circulation and overall vascular health.\nIncreased Mobility: By reducing pain while walking, CILOSTAZONE 50 helps patients increase their mobility and engage in more physical activities.\nPrevention of Blood Clots: Cilostazol’s platelet aggregation inhibition properties help prevent the formation of blood clots, reducing the risk of cardiovascular events.\nDosage and Administration\nDosage\nIntermittent Claudication: The typical dosage for adults is one tablet (50 mg) taken twice daily, 30 minutes before or 2 hours after breakfast and dinner. The dosage may be adjusted by the healthcare provider based on the patient’s response and specific health needs.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. It should be taken on an empty stomach, either 30 minutes before or 2 hours after meals.\nConsistency: For optimal results, take CILOSTAZONE 50 at the same times each day to maintain consistent medication levels in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/cilostazone-50-133551", "price": 101.5, "discountamount": 30.45, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "PAD", "risk", "legs", "life", "Order", "EMAIL", "meals", "water", "limbs", "adults", "people", "dinner", "quality", "patients", "response", "Benefits", "symptoms", "Oral Use", "formation", "breakfast", "full glass", "blood flow", "Prevention", "same times", "one tablet", "discomfort", "Cilostazol", "blood clots", "Consistency", "bloodstream", "CILOSTAZONE", "vasodilation", "Introduction", "sterisonline", "sterispharma", "Reduced Pain", "empty stomach", "CALL/WHATSAPP", "typical dosage", "Key Ingredient", "overall fitness", "optimal results", "longer distances", "effective relief", "cyclic AMP levels", "Increased Mobility", "healthcare provider", "physical activities", "Improved Circulation", "Administration Dosage", "cardiovascular events", "specific health needs", "phosphodiesterase III", "poor blood circulation", "overall vascular health", "Effective Symptom Relief", "intermittent claudication", "peripheral artery disease", "Enhanced Physical Activity", "consistent medication levels", "overall cardiovascular health", "platelet aggregation inhibition properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1814, "imageuri": "https://productimages.withfloats.com/actual/6669749f8c6c791fd3b355dc.png", "tileimageuri": "https://productimages.withfloats.com/tile/6669749f8c6c791fd3b355dc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T10:12:44.844Z", "updatedon": "2024-06-27T06:01:50.923Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cilostazone-50-/1814", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CILOSTAZONE 50 ", "category": "NEUROLOGY RANGE", "tags": [ "CILOSTAZONE 50", "Cilostazol 50mg price", "Cilostazol (50mg)", "Cilostazol 50 uses", "cilostazol 50 mg side effects", "cilostazol 50 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6669524f4722330554e8eaca", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "OXIFYLINE PR 400 ", "description": "OXIFYLINE PR 400 \nPentoxifylline (400mg)\nOXIFYLINE PR 400 contains Pentoxifylline in a strength of 400mg. Pentoxifylline is a medication used to improve blood flow in people with circulation problems. It works by decreasing the viscosity (thickness) of blood and improving its flow through blood vessels. This medication is commonly prescribed to treat conditions like intermittent claudication, a condition characterized by leg pain during physical activity due to poor blood flow. It may also be used to improve symptoms in patients with peripheral artery disease. OXIFYLINE PR 400 should be taken as directed by a healthcare professional.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/oxifyline-pr-400-134198", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "Email", "400mg", "ORDER", "people", "symptoms", "WhatsApp", "leg pain", "problems", "patients", "strength", "viscosity", "thickness", "conditions", "medication", "information", "circulation", "sterispharma", "sterisonline", "OXIFYLINE PR", "blood vessels", "Pentoxifylline", "poor blood flow", "physical activity", "healthcare professional", "intermittent claudication", "peripheral artery disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1777, "imageuri": "https://productimages.withfloats.com/actual/66695253117f82c50b08a60e.png", "tileimageuri": "https://productimages.withfloats.com/tile/66695253117f82c50b08a60e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T07:46:23.941Z", "updatedon": "2024-06-27T07:23:16.506Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/oxifyline-pr-400-/1777", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OXIFYLINE PR 400 ", "category": "RESPIRTORYRANGE", "tags": [ "OXIFYLINE PR 400", "Pentoxifylline 400mg price", "Pentoxifylline 400mg", "oxifyline pr review", "OXIFYLINE PR 400usses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66545a104d19c318441f2e51", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CILOSTAZONE 100", "description": "CILOSTAZONE 100\nCilostazol (100mg)\nCilostazone 100, containing Cilostazol 100mg, is designed to improve blood flow and reduce symptoms of intermittent claudication.\nUses:\nHelps alleviate symptoms such as pain and numbness in the legs during walking.\nIncreases walking distance by improving blood circulation.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n", "price": 191.0, "discountamount": 57.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Uses", "pain", "legs", "symptoms", "numbness", "blood flow", "Cilostazol", "CILOSTAZONE", "walking distance", "blood circulation", "intermittent claudication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1187, "imageuri": "https://productimages.withfloats.com/actual/66545a122c7ce75d2c98f4ce.png", "tileimageuri": "https://productimages.withfloats.com/tile/66545a122c7ce75d2c98f4ce.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-27T10:01:52.102Z", "updatedon": "2024-06-11T12:45:50.952Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cilostazone-100/1187", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cilostazol (100mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e7a474f3481c1f16d3b038", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin (50mg), Metformin Hydrochloride (500mg) & Glimepiride (2mg)", "description": "Sitagliptin 50mg, Metformin Hydrochloride 500mg & Glimepiride 2mg is a combination oral medication designed for the effective management of type 2 diabetes mellitus. This triple-action formula works synergistically to control blood glucose levels by addressing insulin resistance, enhancing insulin secretion, and regulating post-meal sugar spikes. Ideal for patients who require more than one mechanism to maintain stable blood sugar, this combination is often prescribed when monotherapy or dual therapy is insufficient.\n\nUses\n\nManagement of Type 2 Diabetes Mellitus in adults.\n\nHelps in controlling fasting and postprandial blood glucose levels.\n\nRecommended for patients whose blood sugar is not adequately controlled with a single antidiabetic medicine.\n\nCan be used as part of a comprehensive diabetes management plan, including diet and exercise.\n\nKey Benefits\n\nDual Mechanism Control:\n\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity.\n\nGlimepiride stimulates pancreatic beta cells to secrete more insulin.\n\nSitagliptin enhances incretin hormones, leading to better regulation of post-meal glucose levels.\n\nEffective Blood Sugar Management:\nHelps maintain optimal fasting and postprandial glucose levels, reducing the risk of diabetes-related complications.\n\nConvenient Combination Therapy:\nCombines three mechanisms in a single tablet, reducing the pill burden and improving patient compliance.\n\nSupports Overall Health:\nHelps prevent long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular risks associated with diabetes.\n\nPossible Side Effects\n\nWhile generally well-tolerated, some patients may experience:\n\nGastrointestinal issues: nausea, vomiting, diarrhea, or abdominal discomfort (mainly from Metformin).\n\nHypoglycemia (low blood sugar): more likely due to Glimepiride; symptoms include dizziness, sweating, or shakiness.\n\nAllergic reactions: rash, itching, or swelling in rare cases.\n\nOther mild effects: headache, fatigue, or minor changes in taste.\n\nNote: Patients should always consult their doctor before starting this combination and report any unusual symptoms immediately.\n\nConclusion\n\nThe Sitagliptin, Metformin Hydrochloride & Glimepiride combination provides a powerful, multi-targeted approach to managing type 2 diabetes. By tackling high blood sugar from different angles, it supports better glucose control, enhances overall quality of life, and reduces the risk of diabetes-related complications. When used alongside proper diet, exercise, and medical guidance, this combination can be a cornerstone in effective diabetes management.", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2185, "imageuri": "https://productimages.withfloats.com/actual/68e7a47b040520d37b5e6b34.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e7a47b040520d37b5e6b34.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-09T12:03:00.012Z", "updatedon": "2025-10-09T12:03:00.012Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-50mg-metformin-hydrochloride-500mg-glimepiride-2mg-/2185", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-10-02T11:20:20.402Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67e1547f527b20030c4156f0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 5 mg and Metformin Hydrochloride 500 mg", "description": "EMPATECH MET 5/500 is a powerful combination of Empagliflozin 5 mg and Metformin Hydrochloride 500 mg designed to effectively manage Type 2 Diabetes Mellitus. It helps control blood sugar levels, improves insulin sensitivity, and reduces the risk of diabetes-related complications. This dual-action formula works by limiting glucose absorption while enhancing the body's natural ability to utilize insulin, making it a preferred choice for diabetic patients seeking optimal glycemic control.\n \nKey Benefits:\nEffective Blood Sugar Control – Lowers HbA1c levels and maintains stable glucose levels.\nSupports Weight Management – Promotes calorie loss by eliminating excess glucose.\nReduces Cardiovascular Risk – Empagliflozin has heart-protective benefits, reducing the risk of heart-related complications.\nImproves Insulin Sensitivity – Helps the body use insulin more effectively.\nReduces the Risk of Hypoglycemia – Lowers blood sugar without excessive insulin spikes.\n\nHow Does It Work?\n\nEmpagliflozin blocks the SGLT2 (Sodium-Glucose Co-Transporter 2) in the kidneys, preventing glucose reabsorption and allowing excess sugar to be excreted through urine.\nMetformin decreases glucose production in the liver and enhances insulin sensitivity, helping the body use glucose more efficiently.\nTogether, they provide comprehensive diabetes management by regulating blood sugar without causing significant hypoglycemia.\n \nDirections for Use:\n \n\nTake EMPATECH MET 5/500 as prescribed by your doctor.\n\nSwallow the tablet whole with water, preferably with meals to minimize stomach discomfort.\n\nMaintain a balanced diet and regular exercise for optimal results.\n\nDo not stop or change the dosage without consulting your doctor.\n\n \nSide Effects:\n \n\nWhile EMPATECH MET 5/500 is generally well-tolerated, some individuals may experience:\n\nFrequent Urination – Due to glucose excretion in urine.\nMild Stomach Discomfort – Including nausea, bloating, or diarrhea.\nDizziness or Weakness – Especially in the initial stages of treatment.\nUrinary Tract Infections (UTIs) – A possible side effect of increased glucose in urine.\nLactic Acidosis (Rare but Serious) – Symptoms include muscle pain, breathing difficulty, or extreme tiredness; seek medical attention if these occur.", "price": 115.0, "discountamount": 35.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "effectively reduces", "increased glucose", "initial stages", "diarrhea dizziness", "nausea bloating", "glucose excretion", "generally welltolerated", "optimal results", "regular exercise", "balanced diet", "water preferably", "empatech met 5500", "preferred choice", "diabetesrelated complications", "powerful combination", "side effect", "doctor swallow", "empagliflozin 5mg", "doctor side effects", "limiting glucose absorption", "excessive insulin spikes", "utilize insulin making", "work empagliflozin blocks", "regulating blood sugar", "allowing excess sugar", "heartprotective benefits reducing", "bodys natural ability", "dualaction formula works" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2074, "imageuri": "https://productimages.withfloats.com/actual/67e15496bb48c9c5202ecea6.png", "tileimageuri": "https://productimages.withfloats.com/tile/67e15496bb48c9c5202ecea6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-24T12:47:59.972Z", "updatedon": "2025-03-27T12:53:02.808Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-5-mg-and-metformin-hydrochloride-500-mg/2074", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EMPATECH MET 5/500", "category": "DIABETIC RANGE", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin 12.5 mg+metformin 500 mg price", "empagliflozin + metformin combination brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35e1c4d6823e26538d21d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (12.5mg), Metformin Hydrochloride (500mg)", "description": "GLIEMPAFLOZIN MET 12.5mg/500mg is a powerful combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (12.5mg) and Metformin Hydrochloride (500mg), two potent anti-diabetic agents that work synergistically to regulate blood sugar levels. This medication helps in improving glycemic control while reducing the risk of diabetes-related complications. It is prescribed as an adjunct to diet and exercise to enhance blood glucose regulation in adults with type 2 diabetes.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control: Helps in lowering HbA1c levels, leading to better long-term glucose management.\nPromotes Weight Loss: Empagliflozin assists in weight reduction by eliminating excess glucose through urination.\nReduces Cardiovascular Risk: Beneficial for patients with heart-related complications linked to diabetes.\nImproves Insulin Sensitivity: Metformin enhances insulin action, reducing insulin resistance.\nPrevents Kidney Damage: Helps in reducing the burden on kidneys by decreasing glucose reabsorption.\nConvenient Combination Therapy: Eliminates the need for multiple medications by combining two effective drugs in one tablet.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 12.5mg/500mg works through a dual mechanism:\n\nEmpagliflozin blocks SGLT2 in the kidneys, preventing glucose reabsorption and promoting its excretion through urine. This leads to a significant reduction in blood sugar levels.\n\nMetformin lowers hepatic glucose production, decreases intestinal glucose absorption, and enhances insulin sensitivity, ensuring better blood glucose utilization by the body.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as directed by your healthcare provider.\n\nSwallow the tablet whole with a glass of water. Do not crush or chew it.\n\nIt is recommended to take the medication with food to minimize gastrointestinal side effects.\n\nFollow a balanced diet and regular exercise regimen for optimal results.\n\nMonitor blood sugar levels regularly to ensure proper dosage adjustments.\n\n \nSide Effects:\n \n\nAlthough GLIEMPAFLOZIN MET 12.5mg/500mg is well tolerated, some patients may experience mild to moderate side effects, including:\n\nFrequent Urination due to glucose excretion\n\nDehydration or thirst\n\nHypoglycemia (Low Blood Sugar) when used with other anti-diabetic medications\n\nGastrointestinal Issues such as nausea, diarrhea, or stomach discomfort\n\nUrinary Tract Infections (UTIs) due to increased glucose in urine\n\nLactic Acidosis (Rare but Serious) in some cases due to Metformin", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet daily", "balanced diet", "medication helps", "nausea diarrhea", "experience mild", "body directions", "significant reduction", "effective drugs", "multiple medications", "weight reduction", "work synergistically", "empagliflozin 125mg", "cases due", "diabetesrelated complications", "increased glucose", "glucose excretion dehydration", "regular exercise regimen", "metformin hydrochloride 500mg", "frequent urination due", "heartrelated complications linked", "blood glucose utilization", "eliminating excess glucose", "moderate side effects", "gliempaflozin met 125mg500mg", "healthcare provider swallow", "improving glycemic control", "potent antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2050, "imageuri": "https://productimages.withfloats.com/actual/67a35e57b167fbeb7927d316.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35e57b167fbeb7927d316.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:48:28.684Z", "updatedon": "2025-03-17T11:04:23.276Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-12-5mg-metformin-hydrochloride-500mg-/2050", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 12.5mg/ 500mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg", "empagliflozin/metformin 5 mg/1000 mg", "Empagliflozin 12.5 mg brands in India", "empagliflozin 12.5 mg+metformin 500 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35d815432f8f0afe662b4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin 25mg+ metformin hydrochloride (extended release) 1000 mg", "description": "GLIEMPAFLOZIN MET ER is a combination medication used to manage type 2 diabetes mellitus (T2DM) by helping control blood sugar levels effectively. It contains two powerful anti-diabetic agents, Empagliflozin and Metformin Hydrochloride (Extended Release), which work together to enhance glucose regulation and reduce the risk of diabetes-related complications. This medication is recommended for patients who require additional glycemic control beyond lifestyle changes and monotherapy treatments.\n\n \nKey Benefits\n \n\n Effective Blood Sugar Control – Helps reduce and maintain optimal blood glucose levels in type 2 diabetic patients.\nWeight Management – Empagliflozin promotes caloric loss through urinary glucose excretion, potentially aiding in weight reduction.\nReduced Risk of Cardiovascular Diseases – Beneficial for heart health, lowering the risk of cardiac complications in diabetic patients.\nInsulin Sensitivity Improvement – Metformin enhances insulin function, reducing insulin resistance.\nLower Risk of Hypoglycemia – A balanced mechanism of action ensures stable blood glucose levels without sudden drops.\nKidney Protection – Empagliflozin may help protect against diabetic nephropathy by reducing kidney stress.\nExtended-Release Formula – Ensures long-lasting blood sugar control with a once-daily dosage for improved patient compliance.\n \nHow Does It Work?\n \n\nEmpagliflozin (SGLT2 Inhibitor) – Blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting its excretion through urine, thereby reducing blood sugar levels.\nMetformin Hydrochloride (Biguanide) – Reduces glucose production in the liver, enhances insulin response, and delays glucose absorption in the digestive tract.\nTogether, they provide a dual action approach for better glycemic control while minimizing side effects like hypoglycemia.\n \nDirections for Use\n \n\nDosage: Take one tablet per day, preferably with food or as directed by your healthcare provider.\nSwallow whole with a glass of water; do not crush or chew.\n Maintain a healthy diet and follow a regular exercise routine for optimal results.\nRegular monitoring of blood sugar levels is advised.\nDo not stop taking this medication without consulting your doctor.\n\n \nSide Effects:\n \n\nSome individuals may experience mild to moderate side effects, including:\n\nFrequent urination (due to glucose excretion)\nDehydration (increased fluid loss)\nNausea, vomiting, or stomach upset\nDiarrhea or constipation\nMetallic taste in the mouth\nLow blood pressure (Hypotension)\nVitamin B12 deficiency (with long-term use of Metformin)\nUrinary tract infections (UTIs) or genital infections\n Seek medical attention if you experience severe allergic reactions, extreme dizziness, or difficulty breathing.", "price": 245.0, "discountamount": 74.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "combination medication", "hypoglycemia directions", "oncedaily dosage", "difficulty breathing", "experience mild", "stop taking", "healthy diet", "chew maintain", "day preferably", "glycemic control", "digestive tract", "sglt2 protein", "diabetic nephropathy", "balanced mechanism", "cardiac complications", "diabetesrelated complications", "constipation metallic taste", "stomach upset diarrhea", "frequent urination due", "moderate side effects", "doctor side effects", "blood sugar levels", "regular exercise routine", "healthcare provider swallow", "minimizing side effects", "dual action approach", "delays glucose absorption", "improved patient compliance", "heart health lowering", "cardiovascular diseases beneficial", "enhance glucose regulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2049, "imageuri": "https://productimages.withfloats.com/actual/67a35d9d1b599c6f20ba1fa7.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35d9d1b599c6f20ba1fa7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:45:53.712Z", "updatedon": "2025-03-27T09:45:21.627Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-25mg-metformin-hydrochloride-extended-release-1000-mg/2049", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET ER ", "category": "DIABETIC RANGE", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin + metformin brand name in india", "empagliflozin + metformin combination brand name", "empagliflozin 12.5 mg+metformin 500 mg price", "Empagliflozin and metformin hydrochloride extended-release tablets", "Empagliflozin and metformin hydrochloride tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }